Cargando…

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19

Serological diagnostic assays are essential tools for determining an individual’s protection against viruses like SARS-CoV-2, tracking the spread of the virus in the community, and evaluating population immunity. To assess the diversity and quality of the anti-SARS-CoV-2 antibody response, we have c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrios, Marilou H., Nicholson, Suellen, Bull, Rowena A., Martinello, Marianne, Rawlinson, William, Mina, Michael, Post, Jeffrey J., Hudson, Bernard, Gilroy, Nicole, Lloyd, Andrew R., Konecny, Pamela, Mordant, Francesca, Catton, Mike, Subbarao, Kanta, Caly, Leon, Druce, Julian, Netter, Hans J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458948/ https://www.ncbi.nlm.nih.gov/pubmed/37630545 http://dx.doi.org/10.3390/microorganisms11081985

Ejemplares similares

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
por: Nicholson, Suellen, et al.
Publicado: (2021)

Prolonged Detection of Japanese Encephalitis Virus in Urine and Whole Blood in a Returned Short-term Traveler
por: Huang, G Khai Lin, et al.
Publicado: (2017)

High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
por: Gupta, Money, et al.
Publicado: (2022)

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
por: Caly, Leon, et al.
Publicado: (2020)

Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort
por: Bailie, C. R., et al.
Publicado: (2021)

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
por: Rowntree, Louise C, et al.
Publicado: (2021)

Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection
por: Bond, K.A., et al.
Publicado: (2021)

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
por: Thevarajan, Irani, et al.
Publicado: (2020)

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
por: Balachandran, Harikrishnan, et al.
Publicado: (2022)

An update on Covid-19 serology
por: Kinsella, Paul M., et al.
Publicado: (2022)

Lymphocytic Choriomeningitis Virus Infection, Australia
por: Caly, Leon, et al.
Publicado: (2022)

The First Isolation and Whole Genome Sequencing of Murray Valley Encephalitis Virus from Cerebrospinal Fluid of a Patient with Encephalitis
por: Russell, Jessica S., et al.
Publicado: (2018)

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
por: Netter, Hans J., et al.
Publicado: (2021)

Long-term persistence of RBD(+) memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
por: Abayasingam, Arunasingam, et al.
Publicado: (2021)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
por: Baz, Mariana, et al.
Publicado: (2022)

Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection
por: Chang, Jessie J.-Y., et al.
Publicado: (2021)

A unique cytotoxic CD4(+) T cell‐signature defines critical COVID‐19
por: Baird, Sarah, et al.
Publicado: (2023)

Utility of a Stressed Single Nucleotide Polymorphism (SNP) Real-Time PCR Assay for Rapid Identification of Measles Vaccine Strains in Patient Samples
por: Tran, Thomas, et al.
Publicado: (2018)

Correction: Rapid Evolution of Pandemic Noroviruses of the GII.4 Lineage
por: Bull, Rowena A., et al.
Publicado: (2010)

Rapid Evolution of Pandemic Noroviruses of the GII.4 Lineage
por: Bull, Rowena A., et al.
Publicado: (2010)

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
por: Shrestha, Lok Bahadur, et al.
Publicado: (2022)

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
por: Rouet, Romain, et al.
Publicado: (2023)

SARS–associated Coronavirus Replication in Cell Lines
por: Kaye, Matthew, et al.
Publicado: (2006)

Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings
por: Chong, Brian S.W., et al.
Publicado: (2020)

Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
por: Messina, Nicole L, et al.
Publicado: (2022)

Reality Check of Laboratory Service Effectiveness during Pandemic (H1N1) 2009, Victoria, Australia
por: Catton, Michael, et al.
Publicado: (2011)

Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection
por: Chang, Jessie J.-Y., et al.
Publicado: (2022)

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
por: Walker, Gregory J., et al.
Publicado: (2021)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

Norovirus Recombination in ORF1/ORF2 Overlap
por: Bull, Rowena A., et al.
Publicado: (2005)

A Bioinformatics Pipeline for the Analyses of Viral Escape Dynamics and Host Immune Responses during an Infection
por: Leung, Preston, et al.
Publicado: (2014)

Erratum to “A Bioinformatics Pipeline for the Analyses of Viral Escape Dynamics and Host Immune Responses during an Infection”
por: Leung, Preston, et al.
Publicado: (2014)

Next generation deep sequencing and vaccine design: today and tomorrow
por: Luciani, Fabio, et al.
Publicado: (2012)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017–18 Australian epidemic
por: Chamings, Anthony, et al.
Publicado: (2019)

Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States
por: Karelehto, Eveliina, et al.
Publicado: (2019)

Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection
por: Walker, Melanie R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gng2992d4o0vsia5cmbq2t8bnp